デフォルト表紙
市場調査レポート
商品コード
1087237

止血剤と組織シーラントの世界市場:産業分析、動向、市場規模、予測(~2028年)

Hemostats and tissue Sealants Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

出版日: | 発行: Infinium Global Research (IGR) | ページ情報: 英文 100 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
止血剤と組織シーラントの世界市場:産業分析、動向、市場規模、予測(~2028年)
出版日: 2022年05月25日
発行: Infinium Global Research (IGR)
ページ情報: 英文 100 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の止血剤と組織シーラント市場は、2022~2028年の予測期間において、著しいCAGRで成長すると予測されています。

当レポートでは、世界の止血剤と組織シーラント市場について調査分析し、市場の促進要因、抑制要因、市場機会、製品・地域別市場分析、企業プロファイル等に関する情報を提供しています。

目次

第1章 序文

  • レポートの説明
  • 調査方法
  • 調査アプローチ

第2章 エグゼクティブサマリー

  • 止血剤と組織シーラント市場のハイライト
  • 止血剤と組織シーラント市場の予測
  • 止血剤と組織シーラント市場の地域のハイライト

第3章 世界の止血剤と組織シーラント:市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 止血剤と組織シーラント市場に対するCOVID-19の影響分析
  • ポーターのファイブフォース分析
  • IGR-成長マトリックス分析
    • IGR-成長マトリックス分析:製品別
    • IGR-成長マトリックス分析:地域別
  • 止血剤と組織シーラント市場のバリューチェーン分析

第4章 止血剤と組織シーラント市場のマクロ指標分析

第5章 世界の止血剤と組織シーラント市場:製品別

  • 止血剤
  • 組織シーラントと接着剤
  • フィブリンシーラント

第6章 世界の止血剤と組織シーラント市場:地域別(2022~2028年)

  • 北米
    • 製品別
    • 国別
  • 欧州
    • 製品別
    • 国別
  • アジア太平洋
    • 製品別
    • 国別
  • その他の地域
    • 製品別
    • サブ地域別

第7章 企業プロファイルと競合情勢

  • 競合情勢
  • 企業プロファイル
    • BARD, A Becton, Dickinson Company
    • Baxter International, Inc.
    • Cardinal Health, Inc.
    • Cohera Medical, Inc.
    • CryoLife, Inc.
    • CSL Behring LLC
    • Ethicon US, LLC
    • HyperBranch Medical Technology, Inc.
    • Integra Lifesciences Corporation
    • Smith & Nephew PLC
目次
Product Code: HC0140

The report on the global hemostats and tissue sealants market provides qualitative and quantitative analysis for the period from 2020 to 2028. The report predicts the global hemostats and tissue sealants market to grow with a significant CAGR over the forecast period from 2022-2028. The study on hemostats and tissue sealants market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.

The report on hemostats and tissue sealants market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global hemostats and tissue sealants market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global hemostats and tissue sealants market over the period of 2020 to 2028. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Increasing number of surgeries worldwide
  • Increasing popularity of mi procedures

2) Restraints

  • Lack of awareness about these devices

3) Opportunities

  • Development of new tissue sealants and hemostats

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global hemostats and tissue sealants market is segmented on the basis of product.

The Global Hemostats and tissue Sealants Market by Product

  • Hemostats
  • Tissue Sealants and Adhesives
  • Fibrin Sealants

Company Profiles

The companies covered in the report include

  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Cardinal Health, Inc.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • CSL Behring LLC
  • Ethicon US, LLC
  • HyperBranch Medical Technology, Inc.
  • Integra Lifesciences Corporation
  • Smith & Nephew PLC

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the hemostats and tissue sealants market.

2. Complete coverage of all the segments in the hemostats and tissue sealants market to analyze the trends, developments in the global market and forecast of market size up to 2028.

3. Comprehensive analysis of the companies operating in the global hemostats and tissue sealants market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Hemostats and Tissue Sealants Market Highlights
  • 2.2. Hemostats and Tissue Sealants Market Projection
  • 2.3. Hemostats and Tissue Sealants Market Regional Highlights

3. Global Hemostats and Tissue Sealants Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Hemostats and Tissue Sealants Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Product
    • 3.5.2. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Hemostats and Tissue Sealants Market

4. Hemostats and Tissue Sealants Market Macro Indicator Analysis

5. Global Hemostats and Tissue Sealants Market by Product

  • 5.1. Hemostats
  • 5.2. Tissue Sealants and Adhesives
  • 5.3. Fibrin Sealants

6. Global Hemostats and Tissue Sealants Market by Region 2022-2028

  • 6.1. North America
    • 6.1.1. North America Hemostats and Tissue Sealants Market by Product
    • 6.1.2. North America Hemostats and Tissue Sealants Market by Country
  • 6.2. Europe
    • 6.2.1. Europe Hemostats and Tissue Sealants Market by Product
    • 6.2.2. Europe Hemostats and Tissue Sealants Market by Country
  • 6.3. Asia-Pacific
    • 6.3.1. Asia-Pacific Hemostats and Tissue Sealants Market by Product
    • 6.3.2. Asia-Pacific Hemostats and Tissue Sealants Market by Country
  • 6.4. RoW
    • 6.4.1. RoW Hemostats and Tissue Sealants Market by Product
    • 6.4.2. RoW Hemostats and Tissue Sealants Market by Sub-region

7. Company Profiles and Competitive Landscape

  • 7.1. Competitive Landscape in the Global Hemostats and Tissue Sealants Market
  • 7.2. Companies Profiles
    • 7.2.1. BARD, A Becton, Dickinson Company
    • 7.2.2. Baxter International, Inc.
    • 7.2.3. Cardinal Health, Inc.
    • 7.2.4. Cohera Medical, Inc.
    • 7.2.5. CryoLife, Inc.
    • 7.2.6. CSL Behring LLC
    • 7.2.7. Ethicon US, LLC
    • 7.2.8. HyperBranch Medical Technology, Inc.
    • 7.2.9. Integra Lifesciences Corporation
    • 7.2.10. Smith & Nephew PLC